Mexitil and Panobinostat Lactate
Determining the interaction of Mexitil and Panobinostat Lactate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Panobinostat may increase the blood levels and effects of mexiletine. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Coadministration with panobinostat may increase the plasma concentrations of drugs that are substrates of CYP450 2D6. The mechanism is decreased clearance due to inhibition of CYP450 2D6 activity by panobinostat. When a single 60 mg dose of dextromethorphan, a CYP450 2D6 probe substrate, was coadministered with panobinostat (20 mg once per day on days 3, 5, and 8) in 14 patients with advanced cancer, dextromethorphan peak plasma concentration (Cmax) increased by 20% to 200% (median 80%) and systemic exposure (AUC) increased by 20% to 130% (median 60%) compared to administration of dextromethorphan alone.
MANAGEMENT: Given the high interpatient variability with respect to magnitude of interaction, concomitant use of panobinostat with sensitive CYP450 2D6 substrates (e.g., atomoxetine, desipramine, dextromethorphan, metoprolol, nebivolol, perphenazine, tolterodine, venlafaxine) or CYP450 2D6 substrates that have a narrow therapeutic index (e.g., pimozide, thioridazine) should generally be avoided. Caution is advised when panobinostat is used with other drugs that are metabolized by CYP450 2D6.
- "Product Information. Farydak (panobinostat)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: panobinostat
Brand name: Farydak
Synonyms: Panobinostat
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mexitil-Panocaps
- Mexitil-PanOxyl
- Mexitil-Panoxyl Soap
- Mexitil-PanOxyl Wash
- Mexitil-PanOxyl-4 Creamy Wash
- Mexitil-PanOxyl-8 Creamy Wash
- Panobinostat Lactate-MG 217 Topical
- Panobinostat Lactate-MG Plus Protein
- Panobinostat Lactate-MG217 Medicated Tar
- Panobinostat Lactate-Mg217 Sal-Acid Topical
- Panobinostat Lactate-Mi-Acid
- Panobinostat Lactate-Mi-Acid Double Strength